GC Holding has appointed Dr Per Falk as CEO effective 1 Oct 2024. The announcement was made by Makoto Nakao, chairman of GC Holding, and its board of directors.
This decision strengthens GC’s corporate governance by setting up GC Holding as GC group parent company and major shareholder. This builds on GC’s history as an organisation founded in 1921 in Japan and run by the Nakao family for over 100 years. In 1934, Kiyoshi Nakao first transformed the GC Chemical Research Laboratory organisation into a corporate structure to cope with business transformation and ensure future growth. GC continued to grow into a global company under the leadership of President Toshio Nakao. The company broke new ground by launching the “Fuji” brand of glass ionomer in 1977, when Makoto Nakao was appointed executive director and then president in 1983. On 1 Oct 2024, Ayako Nakao was made a member of GC Holding’s board of directors.
Dr. Falk’s appointment coincides with GC’s 103rd anniversary. Dr Falk has been a member of GC’s board of directors for two and a half years. His career spans 25 years in pharmaceutical industry and he joins GC from Ferring Pharmaceuticals, where he was President.
Nakao expressed his confidence in Dr. Falk’s leadership: “It is very fortunate for the GC Group and its shareholders that Dr Per Falk will take on the CEO responsibility. His professional experience and knowledge of GC business, combined with the trust of the Nakao family, place him in an ideal position to become CEO of the GC Group.”
Dr Falk commented: “I am very excited over the opportunity to lead GC in its next growth phase and am truly honored by the trust and confidence given to me with this appointment. I look forward to working closely with our chairman, Mr Nakao, and all our skilled and dedicated colleagues to grow GC’s position as a strong contributor in the global dental and oral health sector.”
Under the leadership of GC Holding, headquartered in Lucerne, Switzerland, and its Board of Directors, GC is focused on its future to further develop its legacy of excellence in dental care, create value for stakeholders and improve oral health.
